What should you know about Igenomix PGT-A results?

PGT-A, or preimplantation genetic testing for aneuploidy, examines genetic material from a small sample of cells associated with an embryo. The report may classify an embryo as euploid, aneuploid, or mosaic, depending on the chromosome pattern detected in the sample. A result is about the tested cells; it is not a full genetic diagnosis of a future child.

A mosaic finding means the sample contained a mixture of cell lines. Laboratories may also report a result as inconclusive when there is not enough usable information. Testing methods such as next-generation sequencing can identify chromosome copy-number patterns, but interpretation still depends on the embryo, the laboratory report, and your clinical history.

Ask for the complete report and have your fertility specialist explain each embryo's category, the confidence or limitations described by the laboratory, and how the result fits your treatment plan. Confirm whether genetic counselling is available, particularly for mosaic or inconclusive findings. Do not discard or select an embryo based on a label you have read without discussing the report.

Arrange a prompt consultation if a result is unclear, conflicts with earlier information, or leaves you unsure about consent or embryo choices. Seek emotional support as well if the report is distressing; fertility decisions can carry a substantial personal burden even when the laboratory wording is technically clear.

Ask what was tested, which result category applies, what the report cannot tell you, whether confirmatory testing is relevant, and how the finding changes the options for transfer, storage, or further fertility treatment.